Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(2007): Lim AK+, Intern Med J 37(1), 55
(2007): Tejedor A+, Curr Med Res Opin 23(3), 505
(2007): Tostivint I+, NephrolDialTransplant22(3), 880
(2006): Anglicheau D+, Kidney Int 70(6), 1019
(2006): Chapman JR+, NephrolDialTransplant21(8), 2060
(2006): Dziewanowski K+, Kardiol Pol 64(5), 522
(2005): Cantarovich D+, Transplantation 79(1), 72
(2005): Dubus I+, Life Sci 77(26), 3366
(2005): Kuypers DR, Drug Saf 28(2), 153
(2005): Mahmoud I+, NephrolDialTransplant20(4), 735
(2005): Mention K+, Pediatr Transplant 9(2), 201
(2005): Orion E+, Clin Dermatol 23(2), 182
(2005): Ulinski T+, Pediatr Nephrol 20(4), 482
(2004): Baran DA+, Am J Cardiovasc Drugs 4(1), 21
(2004): Busauschina A+, Transplant Proc 36(2 Suppl), 229S
(2004): Cattaneo D+, Transplant Proc 36(2 Suppl), 234S
(2004): Hesselink DA+, Transplant Proc 36(2 Suppl), 372S
(2004): Kuypers DR+, Transplantation 78(8), 1204
(2004): Parekh K+, Transplant Proc 36(2 Suppl), 318S
(2004): Paul LC+, Transplant Proc 36(2 Suppl), 224S
(2004): Raafat RH+, Am J Kidney Dis 44(1), 50
(2004): Willetts IE+, Transplant Proc 36(2 Suppl), 211S
(2003): Burdmann EA+, Semin Nephrol 23(5), 465
(2003): Cattran DC, Semin Nephrol 23(2), 234
(2003): Dudley J+, NephrolDialTransplant18(2), 403
(2003): Flechner SM, Transplant Proc 35(3 Suppl), 118S
(2003): Parra Cid T+, Toxicology 189(1–2), 99
(2003): Suwelack B+, Transpl Int 16(5), 313
(2003): Ziolkowski J+, Transplant Proc 35(6), 2307
(2002): Assan R+, Diabetes Metab Res Rev 18(6), 464
(2002): Furrer K+, Swiss Med Wkly 132(23–24), 316
(2002): Ganesan V+, Pediatr Nephrol 17(3), 225
(2002): Iijima K+, Kidney Int 61(5), 1801
(2002): Isnard Bagnis C+, JAmSocNephrol13(12), 2962
(2002): Israni A+, Am J Kidney Dis 39(3), E16
(2002): Khanna A+, Kidney Int 62(6), 2257
(2002): Lytton SD+, Clin Exp Immunol 127(2), 293
(2002): Markham T+, Clin Exp Dermatol 27(2), 111
(2002): McClure SL+, Drug Saf 25(13), 913
(2001): Campistol JM+, Transplantation 71(11 Suppl), SS42
(2001): Derici U+, Acta Neurol Belg 101(2), 124
(2001): Gossmann J+, Kidney Blood Press Res 24(2), 111
(2001): Jankauskiene A+, Clin Nephrol 56(6), S27
(2001): Morales JM+, NephrolDialTransplant16 Suppl 1, 121
(2001): Pescovitz MD+, Am J Kidney Dis 38(4 Suppl 2), S16
(2001): Sijpkens YW+, Clin Nephrol 55(2), 149
(2001): Takeda A+, Clin Transplant 15 Suppl 5, 22
(2001): Wondimu B+, Int J Paediatr Dent 11(6), 424
(2000): Davison SC+, Br J Dermatol 143(2), 405
(2000): de Mattos AM+, Am J Kidney Dis 35(2), 333
(2000): Seikaly MG+, Pediatr Nephrol 14(3), 214
(1999): Ponticelli C+, Kidney Int 55(5), 2075
(1999): Soccal PM+, Transplantation 68(1), 164
(1998): Andoh TF+, Curr Opin Nephrol Hypertens 7(3), 265
(1998): Bagnis C+, Arch Mal Coeur Vaiss 91(4), 411
(1998): Branten AJ+, NephrolDialTransplant13(2), 423
(1998): Fisher NC+, Transplantation 66(1), 59
(1998): Madsen JK+, NephrolDialTransplant13(9), 2327
(1998): Min DI+, Pharmacotherapy 18(2), 282
(1998): Powles AV+, Br J Dermatol 138(3), 443
(1998): Solez K+, Transplantation 66(12), 1736
(1998): Vercauteren SB+, Kidney Int 54(2), 536
(1997): Andoh TF+, Semin Nephrol 17(1), 34
(1997): Bennett WM, Int J Dermatol 36 Suppl 1, 11
(1997): Carmellini M+, Transplantation 64(1), 164
(1997): Chan C+, Transplantation 63(10), 1435
(1997): Charnick SB+, Ther Drug Monit 19(1), 17
(1997): Filler G+, NephrolDialTransplant12(8), 1668
(1997): Goldstein DJ+, Transplantation 63(5), 664
(1997): Goral S+, J Heart Lung Transplant 16(11), 1106
(1997): Pratschke J+, Transplantation 64(6), 938
(1997): Simon N+, Int J Clin Pharmacol Res 17(4), 133
(1997): Simon N+, Therapie 52(2), 151
(1997): Woolfson RG+, NephrolDialTransplant12(10), 2054
(1996): Bennett WM, Int J Clin Pharmacol Ther 34(11), 515
(1996): Vescovi P+, Minerva Stomatol 45(11), 523
(1996): Wissmann C+, JAmSocNephrol7(12), 2677
Neurotoxicity
(2001): Derici U+, Acta Neurol Belg 101(2), 124
(2001): Wondimu B+, Int J Paediatr Dent 11(6), 424
(1997): Pratschke J+, Transplantation 64(6), 938
Pseudolymphoma
(2003): Hivnor C+, Arch Dermatol 139(10), 1373
(1993): Kerl H+, Dermatology in General Medicine McGraw-Hill
New York
(1990): Gupta AK+, JAmAcadDermatol23(6), 1137
(1988): Brown MD+, Arch Dermatol 124(7), 1097
(1988): Thestrup-Pedersen K+, Dermatologica 177, 376
Pseudoporphyria
(2003): Hivnor C+, Arch Dermatol 139(10), 1373
Rhabdomyolysis
(2007): Burton JR+, Ann Pharmacother 41(1), 133
(2005): Tong J+, Bone Marrow Transplant 36(8), 739 (with
simvastatin)
(2003): Chiffoleau A+, Therapie 58(2), 168 (with verapamil and
simvastatin)
(2003): Gumprecht J+, Med Sci Monit 9(9), CS89 (with
simvastatin)
(2002): Cassidy JV+, Paediatr Anaesth 12(8), 729
(1999): Maltz HC+, Ann Pharmacother 33(11), 1176 (with
atorvastatin)
(1995): Meier C+, Schweiz Med Wochenschr 125(27), 1342 (with
simvastatin)
(1994): Alejandro DS+, JAmSocNephrol5(2), 153 (with
lovastatin)
(1992): Blaison G+, Rev Med Interne 13(1), 61 (with simvastatin)
(1988): Corpier CL+, JAMA 260(2), 239 (lovastatin)
(1988): Tobert JA, Am J Cardiol 62, 28J (with lovastatin)
Thrombosis
(1996): Vescovi P+, Minerva Stomatol 45(11), 523
Tumors
(2001): Werth V, Dermatology Times 15
CYCLOTHIAZIDE
Trade names: Anhydron; Doburil; Valmiran
Indications: Edema, hypertension
Category: Diuretic, thiazide
Half-life: N/A
Clinically important, potentially hazardous interactions
with: digoxin
Reactions
CYCLOTHIAZIDE 157
Skin
Exanthems (